Stoke Therapeutics STOK
NASDAQ STOK
$27.25 +0.04 (+0.15%)
As of: Nov 11, 2026 · 11:16 AM EST

Stoke Therapeutics (STOK) Shares Outstanding (Diluted) (2018 - 2026)

Updated

Stoke Therapeutics' Weighted Average Shares Outstanding (Diluted) came in at 66.02 million for Q3 2026, up 12.6% from 58.61 million a year earlier and unchanged from the prior quarter.

Analysis

Stoke Therapeutics (STOK) Shares Outstanding (Diluted) (2018 - 2026) Analysis & Trends

For FY2025, Stoke Therapeutics' Weighted Average Shares Outstanding (Diluted) was 59.22 million, up 9.6% from FY2024.

  • Weighted Average Shares Outstanding (Diluted) has increased in each of the last four years, with a four-year compound annual growth rate of 12.7% (FY2021 to FY2025).
  • Going back by year, Weighted Average Shares Outstanding (Diluted) was 54.01 million in FY2024 (+22.8%), 43.99 million in FY2023 (+13.1%), 38.9 million in FY2022 (+5.9%) and 36.74 million in FY2021.
  • Year-over-year, Weighted Average Shares Outstanding (Diluted) has increased for 18 consecutive quarters, with growth averaging 12.7% over the last eight quarters.
  • The year-over-year growth in Weighted Average Shares Outstanding (Diluted) has ranged between 4.0% (Q3 2025) and 28.4% (Q1 2025) over the last five years.
  • Business Quant data shows STOK's Weighted Average Shares Outstanding (Diluted) at 66.02 million (Q2 2026), 63.06 million (Q1 2026) and 59.22 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 893.40 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.45 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 1.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.48 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 1.96 Bn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.56 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 546.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.25 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 5.75 Bn
10 Stoke Therapeutics 1.76 Bn 523.36 Mn - 68.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 68.36 Mn
Jun 30, 2026 66.02 Mn
Mar 31, 2026 63.06 Mn
Dec 31, 2025 59.22 Mn
Sep 30, 2025 58.61 Mn
Jun 30, 2025 58.35 Mn
Mar 31, 2025 59.40 Mn
Dec 31, 2024 54.01 Mn
Sep 30, 2024 56.34 Mn
Jun 30, 2024 55.77 Mn
Mar 31, 2024 46.25 Mn
Dec 31, 2023 43.99 Mn
Sep 30, 2023 44.27 Mn
Jun 30, 2023 44.19 Mn
Mar 31, 2023 42.54 Mn
Dec 31, 2022 38.90 Mn
Sep 30, 2022 39.26 Mn
Jun 30, 2022 39.26 Mn
Mar 31, 2022 37.45 Mn
Dec 31, 2021 36.74 Mn
API Access

Stoke Therapeutics Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=STOK&period=max&api_key=YOUR_API_KEY